Experimental CAR T-Cell therapy targets lupus in small trial
NCT ID NCT06038474
First seen Jan 04, 2026 · Last updated May 28, 2026 · Updated 18 times
Summary
This early study tests a new treatment called Descartes-08 for people with systemic lupus erythematosus (SLE), an autoimmune disease. The therapy uses a patient's own immune cells, modified to attack lupus-related cells. The main goals are to check safety and see if it can reduce disease activity. Only 6 adults with active lupus despite other treatments are enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profound Research LLC
Oceanside, California, 92056, United States
Conditions
Explore the condition pages connected to this study.